Clinical Trial
doi: 10.1016/s0140-6736(76)91322-2.
Letter: Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients
- PMID: 54725
- DOI: 10.1016/s0140-6736(76)91322-2
Item in Clipboard
Clinical Trial
Letter: Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients
Lancet.
.
No abstract available
Similar articles
-
Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.Lancet. 1975 Aug 30;2(7931):376-7. Lancet. 1975. PMID: 51188 Clinical Trial.
-
Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.Lancet. 1974 Dec 21;2(7895):1512-3. doi: 10.1016/s0140-6736(74)90249-9. Lancet. 1974. PMID: 4140421 Clinical Trial. No abstract available.
-
Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients.Lancet. 1975 Oct 11;2(7937):707. doi: 10.1016/s0140-6736(75)90803-x. Lancet. 1975. PMID: 52078 No abstract available.
-
[Hepatitis B immune serum globulin].Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):371-7. Nihon Rinsho. 1995. PMID: 12442412 Review. Japanese. No abstract available.
-
Passive immunization against hepatitis B: a review of recent studies and comment on current aspects of control.Am J Epidemiol. 1978 Feb;107(2):77-86. doi: 10.1093/oxfordjournals.aje.a112520. Am J Epidemiol. 1978. PMID: 341692 Review.
Cited by
-
Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars.World J Gastroenterol. 2017 Jul 7;23(25):4473-4479. doi: 10.3748/wjg.v23.i25.4473. World J Gastroenterol. 2017. PMID: 28740335 Free PMC article.